Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, S Fujioka, T Takaki… - Journal of …, 2011 - Wiley Online Library
Abstract Background and Aim: Ursodeoxycholic acid (UDCA) has been widely used in the
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, S ichi Fujioka… - Journal of …, 2011 - okayama.elsevierpure.com
抄録 Background and Aim: Ursodeoxycholic acid (UDCA) has been widely used in the
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
[引用][C] Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y TAKEUCHI, F IKEDA, K YAMAMOTO… - Journal of …, 2011 - pascal-francis.inist.fr
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis
showing refractory response to ursodeoxycholic acid CNRS Inist Pascal-Francis CNRS …
showing refractory response to ursodeoxycholic acid CNRS Inist Pascal-Francis CNRS …
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, SI Fujioka… - Journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Background and aim Ursodeoxycholic acid (UDCA) has been widely used in the treatment
of patients with primary biliary cirrhosis (PBC). However, some patients are refractory to …
of patients with primary biliary cirrhosis (PBC). However, some patients are refractory to …
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, S Fujioka, T Takaki… - … of Gastroenterology and …, 2011 - infona.pl
Background and Aim: Ursodeoxycholic acid (UDCA) has been widely used in the treatment
of patients with primary biliary cirrhosis (PBC). However, some patients are refractory to …
of patients with primary biliary cirrhosis (PBC). However, some patients are refractory to …
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, S Fujioka, T Takaki… - Journal of …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p>< jats: bold> Background and Aim:</jats: bold>
Ursodeoxycholic acid (UDCA) has been widely used in the treatment of patients with primary …
Ursodeoxycholic acid (UDCA) has been widely used in the treatment of patients with primary …
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y Takeuchi, F Ikeda, S ichi Fujioka… - Journal of …, 2011 - okayama.elsevierpure.com
Abstract Background and Aim: Ursodeoxycholic acid (UDCA) has been widely used in the
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
treatment of patients with primary biliary cirrhosis (PBC). However, some patients are …
[引用][C] Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid
Y TAKEUCHI - J Gastroenterol Hepatol, 2011 - cir.nii.ac.jp
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis
showing refractory response to ursodeoxycholic acid | CiNii Research CiNii 国立情報学 …
showing refractory response to ursodeoxycholic acid | CiNii Research CiNii 国立情報学 …